The United States Pharmacopeia today notified stakeholders that it is postponing the official effective dates of several new and revised standards pertaining to pharmaceutical handling until further notice while it reviews appeals to the standards. Those standards include general chapters <795> (Pharmaceutical Compounding – Nonsterile Preparations), <797> (Pharmaceutical Compounding – Sterile Preparations), and <825> (Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging). In addition, due to the pending appeals, USP new general chapter <800> (Hazardous Drugs Handling in Healthcare Settings) will remain official, but only informational and will not be applicable until the appeals process is complete. The AHA in November 2018 urged USP to delay the official dates of both USP <797> and <800> due to expedited implementation and compliance concerns.

Related News Articles

Perspective
Today marks three full years that the COVID-19 public health emergency has existed in the United States. That means for 1,097 days, hospitals and health care…
Headline
AHA today submitted comments on how the Agency for Healthcare Research and Quality can best support the field in advancing patient safety through an…
Headline
The National Quality Forum’s Measure Applications Partnership is accepting public comment through Dec. 7 at 6 p.m. ET on 52 performance measures the…
Headline
Health and Human Services Secretary Xavier Becerra and leaders from the Agency for Healthcare Research and Quality, Centers for Disease Control and Prevention…
Headline
The Department of Health and Human Services will host a Nov. 14 listening session with health care systems and other stakeholders on its plan to create a…
Chairperson's File
Hospital and health system teams have persevered to ensure patients receive safe, quality care during the past nearly three years of the COVID-19 pandemic.…